Familial Adenomatous Polyposis

Overview

4.8 out of 5 (28 Reviews)

Credits

1.50

Post Assessment Questions

10

Start Date

1 Sep 2023

Last Review Date

5 May 2024

Expiration Date

31 Aug 2026

Estimated Time To Finish

90 Minutes


Unlimited Nurse CE

Stay up to date on the latest medical knowledge with 6821 CE activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 8103.5 hours of CE.

Single Activity

Take this single activity

$37.50 1 activity

6 Month Unlimited Nurse CE

Access to all the Unlimited Nurse CE activities in all specialties.

$89 per half year per user

1 Year Unlimited Nurse CE

Access to all the Unlimited Nurse CE activities in all specialties.

$139 per 1 year per user
 
Need Help?  If you have a system or content concerns, please contact support@statpearls.com

Activity Description

Familial adenomatous polyposis is an autosomal dominant polyposis syndrome characterized by mutations in the adenomatous polyposis coli gene. Patients with familial adenomatous polyposis develop hundreds to thousands of polyps throughout the colon and rectum, significantly elevating their lifetime risk of colorectal cancer if left untreated. Moreover, individuals with this condition commonly develop gastric and duodenal polyps, heightening their susceptibility to gastric and duodenal cancers, desmoid fibromatosis, hepatoblastoma, and thyroid cancer. Colectomy is a primary intervention offering substantial risk reduction for colorectal cancer development, emphasizing the importance of timely screening for associated cancers to enable early detection and intervention.

This activity provides healthcare professionals with the knowledge and skills necessary to identify the signs and symptoms of familial adenomatous polyposis, implement appropriate screening techniques, evaluate management options, and establish surveillance protocols for individuals with this condition. By highlighting the pivotal role of the interprofessional care team, this activity underscores the collaborative approach required to effectively care for patients with this complex condition. Participants gain insights into the comprehensive management of familial adenomatous polyposis, ensuring optimal patient outcomes through coordinated and multidisciplinary care delivery.


Target Audience

This activity has been designed to meet the educational needs of physicians, physician associates, nurses, pharmacists, and nurse practitioners.

Learning Objectives

At the conclusion of this activity, the learner will be better able to:

  • Identify clinical manifestations and family history suggestive of familial adenomatous polyposis in patients presenting with colorectal polyps or a family history of colorectal cancer.

  • Implement appropriate screening and surveillance for familial adenomatous polyposis in individuals with suspected or confirmed genetic predisposition.

  • Apply standardized protocols and decision-making algorithms for managing familial adenomatous polyposis.

  • Collaborate with interdisciplinary healthcare team members to coordinate comprehensive care and support for patients with familial adenomatous polyposis.

Disclosures

StatPearls, LLC requires everyone who influences the content of an educational activity to disclose relevant financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant conflict(s) of interest have been mitigated. Hover over contributor names for financial disclosures. Others involved in planning this educational activity have no relevant financial relationships to disclose.

Commercial Support: This activity has received NO commercial support.

Continuing Education Accreditation Information

In support of improving patient care, StatPearls, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

 

Nurses: StatPearls designates this activity for 1.50 ANCC contact hour(s). Nurses should only claim credit commensurate with the extent of their participation in the activity.

Please consult your professional licensing board for information on the applicability and acceptance of continuing education credit for this activity.

Method of Participation and Credit

  1. Register for the activity.    
  2. Review the target audience, learning objectives, and disclosure information.
  3. Study the educational content of the enduring material.
  4. Choose the best answer to each activity test question. To receive credit and a certificate, you must pass the test questions with a minimum score of 100%.
  5. Complete the post-activity assessment survey.

If you have concerns regarding the CE/CME system, please contact support@statpearls.com.

Disclaimer

This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Faculty may discuss investigational products or off-label uses of products regulated by the US Food and Drug Administration. Readers should verify all information before employing any therapies described in this educational activity.

The information provided for this activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The information presented does not necessarily reflect the views of StatPearls or any commercial supporters of educational activities on statpearls.com. StatPearls expressly disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through a participant's misunderstanding of the content.

Unapproved Uses of Drugs/Devices: In accordance with FDA requirements, the audience is advised that information presented in this continuing education activity may contain references to unlabeled or unapproved uses of drugs or devices. Please refer to the FDA-approved package insert for each drug/device for full prescribing/utilization information.

Cancellation Policy: Please see the cancellation policy. StatPearls, LLC reserves the right to cancel any course due to unforeseen circumstances.

 

 
 

Reviews

Goran Gailani O. on 4/1/2022

priya n. on 3/6/2022

The genetic defect is noted as occurring on chromosome 5 in multiple places in the text and on chromosome 6 in one place.

Susan B. on 4/14/2022

Manish Kumar S. on 6/12/2022

Dottie L. on 6/29/2022

K.Navanitha R. on 7/16/2022

Josh H. on 12/5/2022

Wilbert W. on 12/19/2022

Wilbert W. on 1/5/2023

Malcolm B. on 5/14/2023

Christine U. on 7/3/2023

Sweta S. on 6/19/2023

Anuradha S. on 8/22/2023

Gabrielle D. on 8/22/2023

Mahmud M. on 9/22/2023

raoul m. on 10/6/2023

June h. on 10/23/2023

Donn M. on 12/3/2023

Arnbjorn T. on 12/19/2023

Gregory W. on 12/27/2023

Dr Sruthi G. on 2/4/2024

Fariborz M. on 3/7/2024

Klaus M. on 3/7/2024

Mark A. on 3/28/2024

Thomas K. on 4/18/2024

Jennifer R. on 5/22/2024

Craig J. on 7/13/2024

Sarah B. on 8/27/2024

Unlimited Nurse CE

Stay up to date on the latest medical knowledge with 6821 CE activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 8103.5 hours of CE.

Single Activity

Take this single activity

$37.50 1 activity

6 Month Unlimited Nurse CE

Access to all the Unlimited Nurse CE activities in all specialties.

$89 per half year per user

1 Year Unlimited Nurse CE

Access to all the Unlimited Nurse CE activities in all specialties.

$139 per 1 year per user